[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.0, "open": 8.0, "dayLow": 7.7901, "dayHigh": 8.1589, "regularMarketPreviousClose": 8.0, "regularMarketOpen": 8.0, "regularMarketDayLow": 7.7901, "regularMarketDayHigh": 8.1589, "payoutRatio": 0.0, "beta": 0.089, "trailingPE": 0.0011216396, "forwardPE": -4.015075, "volume": 42229, "regularMarketVolume": 42229, "averageVolume": 1893499, "averageVolume10days": 102240, "averageDailyVolume10Day": 102240, "bid": 7.75, "ask": 8.11, "bidSize": 1, "askSize": 1, "marketCap": 17889450, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1788.945, "fiftyDayAverage": 7.926, "twoHundredDayAverage": 55.93125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13627482, "profitMargins": 0.0, "floatShares": 312562, "sharesOutstanding": 2238980, "sharesShort": 101016, "sharesShortPriorMonth": 1309, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0636, "heldPercentInsiders": 0.65449995, "heldPercentInstitutions": 0.00994, "shortRatio": 0.02, "shortPercentOfFloat": 0.1299, "impliedSharesOutstanding": 2238980, "bookValue": 2.29, "priceToBook": 3.4890828, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -6428000, "trailingEps": 7123.5, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 1362.748, "enterpriseToEbitda": -1.316, "52WeekChange": -0.9724862, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 7.99, "recommendationKey": "none", "totalCash": 4275000, "totalCashPerShare": 1.909, "ebitda": -10355000, "totalDebt": 10000, "quickRatio": 5.625, "currentRatio": 5.767, "totalRevenue": 10000, "debtToEquity": 0.275, "revenuePerShare": 0.006, "returnOnAssets": -1.0283101, "returnOnEquity": -2.7680302, "grossProfits": 10000, "freeCashflow": -9424750, "operatingCashflow": -8726000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -1035.8, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.125003, "regularMarketPrice": 7.99, "corporateActions": [], "postMarketTime": 1755906526, "regularMarketTime": 1755892801, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 2.0025012, "postMarketPrice": 8.15, "postMarketChange": 0.15999985, "regularMarketChange": -0.0100002, "regularMarketDayRange": "7.7901 - 8.1589", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1893499, "fiftyTwoWeekLowChange": 4.91, "fiftyTwoWeekLowChangePercent": 1.5941558, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -589.61, "fiftyTwoWeekHighChangePercent": -0.98662984, "fiftyTwoWeekChangePercent": -97.24862, "dividendDate": 1746057600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7123.5, "epsForward": -1.99, "fiftyDayAverageChange": 0.06399965, "fiftyDayAverageChangePercent": 0.008074647, "twoHundredDayAverageChange": -47.941254, "twoHundredDayAverageChangePercent": -0.8571461, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]